SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19730163
Source:
http://linkedlifedata.com/resource/pubmed/id/19730163
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0175668
,
umls-concept:C0242383
,
umls-concept:C0282443
,
umls-concept:C0600518
,
umls-concept:C1514923
,
umls-concept:C1552617
,
umls-concept:C1566537
pubmed:issue
10
pubmed:dateCreated
2009-11-9
pubmed:abstractText
To assess efficacy and safety in the treatment of nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration with intravitreal ranibizumab.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/ranibizumab
pubmed:status
MEDLINE
pubmed:issn
1539-2864
pubmed:author
pubmed-author:AriasLuisL
,
pubmed-author:FernándezMaribelM
,
pubmed-author:Gómez-UllaFranciscoF
,
pubmed-author:MonteroJavierJ
,
pubmed-author:Ruiz-MorenoJose MJM
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1444-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19730163-Aged
,
pubmed-meshheading:19730163-Aged, 80 and over
,
pubmed-meshheading:19730163-Angiogenesis Inhibitors
,
pubmed-meshheading:19730163-Antibodies, Monoclonal
,
pubmed-meshheading:19730163-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:19730163-Choroidal Neovascularization
,
pubmed-meshheading:19730163-Female
,
pubmed-meshheading:19730163-Fluorescein Angiography
,
pubmed-meshheading:19730163-Follow-Up Studies
,
pubmed-meshheading:19730163-Humans
,
pubmed-meshheading:19730163-Injections
,
pubmed-meshheading:19730163-Macular Degeneration
,
pubmed-meshheading:19730163-Male
,
pubmed-meshheading:19730163-Middle Aged
,
pubmed-meshheading:19730163-Retreatment
,
pubmed-meshheading:19730163-Retrospective Studies
,
pubmed-meshheading:19730163-Tomography, Optical Coherence
,
pubmed-meshheading:19730163-Treatment Outcome
,
pubmed-meshheading:19730163-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:19730163-Visual Acuity
,
pubmed-meshheading:19730163-Vitreous Body
pubmed:articleTitle
A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
pubmed:affiliation
Department of Ophthalmology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain. luisarias@telefonica.net
pubmed:publicationType
Journal Article
,
Multicenter Study